AGIO Operating Cash Flow (Statement)
Agios Pharmaceuticals Inc · Operating Cash Flow (Statement)
AGIO Operating Cash Flow (Statement)
Latest reported-$360.60Mperiod ending
AGIO TTM Cash from Operations (-$49.55M → -$360.60M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AGIO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -360,596,000 | |
| -380,408,000 | |
| -372,977,000 | |
| -409,931,000 | |
| -405,998,000 | |
| -401,463,000 | |
| -389,841,000 | |
| -329,162,000 | |
| -306,587,000 | |
| -300,746,000 | |
| -296,062,000 | |
| -289,737,000 | |
| -299,445,000 | |
| -306,926,000 | |
| -309,478,000 | |
| -327,408,000 | |
| -341,241,000 | |
| -384,306,000 | |
| -407,320,000 | |
| -372,624,000 | |
| -355,647,000 | |
| -306,150,000 | |
| -290,759,000 | |
| -334,973,000 | |
| -352,355,000 | |
| -372,709,000 | |
| -370,622,000 | |
| -351,198,000 | |
| -329,448,000 | |
| -308,692,000 | |
| -304,421,000 | |
| -304,688,000 | |
| -318,564,000 | |
| -310,158,000 | |
| -285,232,000 | |
| -262,001,000 | |
| -233,316,000 | |
| -16,503,000 | |
| 38,562,000 | |
| 59,256,000 | |
| 83,471,000 | |
| -70,373,000 | |
| -76,949,000 | |
| -54,195,000 | |
| -52,847,000 | |
| -57,898,000 | |
| -59,353,000 | |
| -65,195,000 | |
| -56,708,000 | |
| -71,459,000 | |
| -56,400,000 | |
| -54,412,000 | |
| -50,831,000 | |
| -45,555,000 | |
| -49,548,000 |